allon therapeutics inc
(NPC:Toronto Stock Exchange)

Executive Profile*

Background*

Dr. Anthony W. Fox, Tony, MD, Ph.D. serves as the Chief Medical Officer of Zogenix Inc. Dr. Fox serves as the President of EBD Consulting Inc. Dr. Fox serves as an Advisor of Clinical Development and Regulatory Affairs of Allon Therapeutics Inc. He also serves as an Advisor of CNS of Rivanna Pharmaceuticals Inc. He serves as Managing Director of FGK Representative Services. He served as President of the consulting firm EBD Group. He served as Chief Medical Officer of ... Conatus Pharmaceuticals Inc. since March 25, 2008. He is a pharmaceutical physician with more than 20 years in the industry. Dr. Fox served as Consulting Clinical Pharmacologist of Oxygen Biotherapeutics, Inc. (also known as Synthetic Blood International Inc). Dr. Fox is trained in cardiovascular medicine with extensive experience in the management of drug development programs through clinical evaluation and regulatory review. From 1994 to 1997, Dr. Fox was Vice-President of Drug Development and Regulatory Affairs at Cypros Pharmaceuticals in Carlsbad, California, where he led two drugs from IND to Phase III. He was Director of Cardiovascular and Anaesthesia clinical research at Glaxo, where he led the US sumatriptan group and chaired the international remifentanil project from 1990 to 1994. He was Group Leader with Procter and Gamble, leading Phase I and II clinical trials and medical affairs. He serves as Director of Symphony Allegro, Inc. He has been Member of Scientific Advisory Board at Ventaira Pharmaceuticals, Inc. since September 17, 2007. He serves as Member of Scientific Advisory Board at NeurAxon Inc. His professional affiliations are : the American College of Clinical Pharmacology, the American Society of Pharmacology and Experimental Therapeutics, and the Society of Apothecaries of London. Dr. Fox is a Charter Member of the American Academy of Pharmaceutical Physicians. He has numerous publications to his credit spanning, industrial, pharmacological, regulatory, and experimental medicine areas. He co-edits "Principles and Practice of Pharmaceutical Medicine" (John Wiley and Son, second edition), which is a major international textbook in its field. He is a Fellow of the Institute of Biology and the Royal College of Physicians, as well as of the Royal's Faculty of Pharmaceutical Medicine. He is a Associate Clinical Professor at Univ Calif San Diego. He is a Chartered Biologist. His numerous publications span many industrial, clinical, and regulatory areas. He spent two years at Emory University Medical School as a Rotary International post-doc, and three years as CIBA-Geigy Fellow in Clinical Pharmacology at Harvard Medical School. He is Consulting Editor for the journal Pharmaceutical Medicine, and one of six editors for Int J Clin Pharmacol Ther. Dr. Fox obtained three degrees from the University of London: BSc major in pharmacology (first class honors) in 1977, his medical degree in 1980 and a Doctorate in Pharmacology in 1988 and a Fellow of the Faculty of Pharmaceutical Medicine (FFPM) of the Royal College of Physicians of London. He holds the Diploma in Pharmaceutical Medicine (Royal Colleges of Physicians, UK).

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NPC:CN	C$0.01 CAD	0.00

COMPETITOR COMPENSATION